SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-004945
Filing Date
2024-04-11
Accepted
2024-04-11 08:30:17
Documents
14
Period of Report
2024-04-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hrmy-20240406x8k.htm   iXBRL 8-K 41602
2 GRAPHIC hrmy-20240406x8k001.jpg GRAPHIC 1167
  Complete submission text file 0001558370-24-004945.txt   164855

Data Files

Seq Description Document Type Size
3 EX-101.SCH hrmy-20240406.xsd EX-101.SCH 3162
4 EX-101.LAB hrmy-20240406_lab.xml EX-101.LAB 15927
5 EX-101.PRE hrmy-20240406_pre.xml EX-101.PRE 10080
17 EXTRACTED XBRL INSTANCE DOCUMENT hrmy-20240406x8k_htm.xml XML 4831
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

IRS No.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39450 | Film No.: 24837195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)